STOCK TITAN

Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Quotient Limited (NASDAQ:QTNT) announced its participation in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The management team will conduct a fireside chat on February 17, 2022, at 8:00 AM ET. This conference is exclusive to BTIG clients, and those interested in a one-on-one meeting or listening to the live event should contact their BTIG representative. Quotient, with over 30 years in transfusion diagnostics, is committed to reshaping diagnostic practices with its innovative MosaiQ platform, which enhances efficiency and reduces costs for laboratories globally.

Positive
  • None.
Negative
  • None.

JERSEY, Channel Islands, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. As part of the conference, the Company will be conducting a fireside chat on Thursday, February 17, 2022 at 8:00am ET.

BTIG hosted events are intended for prospective and existing BTIG clients only. To request a one-on-one meeting with management or to listen to the live event, please contact your BTIG representative with interest.

About Quotient Limited

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.

The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

Contact: IR@quotientbd.com; +41 22 545 52 26

 


FAQ

What is the date and time of Quotient Limited's fireside chat at the BTIG conference?

The fireside chat will take place on February 17, 2022, at 8:00 AM ET.

Who can attend the BTIG MedTech Conference featuring Quotient Limited?

The conference is intended for prospective and existing BTIG clients only.

What technology does Quotient Limited's MosaiQ platform use?

MosaiQ utilizes proprietary multiplex microarray technology for automated diagnostic testing.

Where are Quotient Limited's operations based?

Quotient has operations in Eysins (Switzerland), Edinburgh (Scotland), and Newtown (Pennsylvania).

Who should be contacted for participation in the BTIG conference regarding Quotient Limited?

Interested parties should contact their BTIG representative for meeting requests or to listen to the event.

Quotient Ltd

NASDAQ:QTNT

QTNT Rankings

QTNT Latest News

QTNT Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Switzerland
Eysins